Lecope Syrup contains Levocetirizine 2.5mg per 5ml, an advanced second-generation antihistamine used to alleviate symptoms associated with allergic conditions. Levocetirizine selectively inhibits peripheral H1 receptors, effectively reducing manifestations such as sneezing, rhinorrhea, nasal congestion, and pruritus linked to allergic rhinitis. Additionally, it is indicated for the management of chronic idiopathic urticaria, providing relief from itching and hives. Due to its minimal penetration of the blood-brain barrier, Lecope Syrup exhibits a lower incidence of sedation compared to first-generation antihistamines, making it suitable for pediatric and adult patients requiring sustained symptom control. The syrup formulation facilitates accurate dosing and ease of administration, particularly in children and individuals with swallowing difficulties. Lecope Syrup should be used as directed by a healthcare professional, with dosage adjustments considered in patients with renal impairment. Common adverse effects may include headache, dry mouth, and fatigue, though these are generally mild and transient. Contraindications include hypersensitivity to Levocetirizine or any excipients. Caution is advised when used concomitantly with CNS depressants. Lecope Syrup offers a reliable therapeutic option for managing allergic symptoms, improving patient comfort and quality of life.